Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Peganum harmala is a potential resource for novel treatments - a review
Nativa
14 January 2026
AL-SNAFI A.E.
Open Access
Exploring the Efficacy of Natural Anti-inflammatory Compounds in Neurological Disorders
Nourishing the Brain Diet and Nutrition Strategies in Managing Neurological Disorders
1 January 2026
Samaddar S.
Implications for the role of natural products in Parkinson disease therapy
Archives of Medical Science
2025
Batawi A.H.
Open Access
Experimental Parkinson models and green chemistry approach
Behavioural Brain Research
5 August 2024
Akyazı O.
Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease
CNS and Neurological Disorders Drug Targets
2024
Chaudhary R.
From Plants to Psycho-Neurology: Unravelling the Therapeutic Benefits of Bioactive Compounds in Brain Disorders
Antioxidants
August 2023
Grosso C.
Open Access
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease
Pharmaceuticals
July 2023
Mittal P.
Open Access
Phytotherapeutic alternatives for neurodegenerative dementias: Scientific review, discussion and therapeutic proposal
Phytotherapy Research
March 2023
Acero N.
Open Access
In vivo investigation of the inhibitory effect of Peganum harmala L. and its major alkaloids on ethylene glycol-induced urolithiasis in rats
Journal of Ethnopharmacology
10 January 2023
Rashid S.
Impact of phytomedicines and their novel delivery systems as an alternative for the treatment of neurodegenerative disorders
Phytopharmaceuticals and Herbal Drugs Prospects and Safety Issues in the Delivery of Natural Products
1 January 2023
Nakhate K.
In vivo toxicokinetics of harmine and derivatives H-2-104 in rats
Chinese Journal of New Drugs
2023
Chen B.
Phytochemistry, pharmacology and toxicology of Peganum harmala
Bangladesh Journal of Pharmacology
19 November 2022
Liu C.
Open Access
Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance
Frontiers in Pharmacology
6 October 2022
Rahman M.M.
Open Access
Neurotoxic effects of l-(2-chlorine)phenyl-9-butyl-/J-carboline in mice
Chinese Journal of Hospital Pharmacy
15 May 2022
Zhang L.
Di(2-ethylhexyl) adipate plasticizer triggers hepatic, brain, and cardiac injury in rats: Mitigating effect of Peganum harmala oil
Ecotoxicology and Environmental Safety
15 January 2021
Behairy A.
Open Access
Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review
Life Sciences
15 September 2020
Chang Y.M.
The toxicity assessment of extract of Peganum harmala L. seeds in Caenorhabditis elegans
BMC Complementary Medicine and Therapies
17 August 2020
Miao X.
Open Access
Measurement of equilibrium solubility, oil-water partition coefficients and dissociation constant of DH-004
Chinese Journal of New Drugs
30 July 2020
Abudula R.
Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease
Journal of Ethnopharmacology
12 June 2020
Katchborian-Neto A.
Open Access
Experimental study of antiparkinsonian action of the harmine hydrochloride original compound
Pharmacological Reports
December 2019
Nurmaganbetov Z.S.
Trehalose neuroprotective effects on the substantia nigra dopaminergic cells by activating autophagy and non-canonical Nrf2 pathways
Iranian Journal of Pharmaceutical Research
Summer 2019
Darabi S.
Induced callus from seedlings of Peganum harmala L. And studying harmine compound concentration in vitro and in vivo by GC analysis.
Iraqi Journal of Science
2019
Mutasher H.
Open Access
Medicinal plants in neurodegenerative diseases: Perspective of traditional persian medicine
Current Drug Metabolism
2018
Farzaei M.H.
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Journal of Ethnopharmacology
5 May 2017
Li S.